Evidence map›Paper›PMID 26962086›Full record

ArticleJournal of clinical microbiology2016

Evaluation of Multiplex-Based Antibody Testing for Use in Large-Scale Surveillance for Yaws: a Comparative Study.

Gretchen M Cooley, Oriol Mitja, Brook Goodhew, Allan Pillay, Patrick J Lammie, Arnold Castro, Penias Moses, Cheng Chen, Tun Ye, Ronald Ballard and 1 more

Open access · hybridAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Multiplex Bead Assay for the Serological Surveillance of Measles and Rubella.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Gretchen M CooleyCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Oriol MitjaLihir Medical Center, International SOS, Newcrest Mining, Lihir Island, Papua New Guinea University of Barcelona, Barcelona, Spain.
Brook GoodhewCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Allan PillayCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Patrick J LammieCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Arnold CastroCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Penias MosesLihir Medical Center, International SOS, Newcrest Mining, Lihir Island, Papua New Guinea.
Cheng ChenCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Tun YeCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Ronald BallardCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Diana L MartinCenters for Disease Control and Prevention, Atlanta, Georgia, USA hzx3@cdc.gov.
Centers for Disease Control and Prevention · USPapua New Guinea Institute of Medical Research · PGUniversitat de Barcelona · ES

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

WHO has targeted yaws for global eradication by 2020. The program goals are to interrupt the transmission in countries where yaws is endemic and to certify countries as yaws free where yaws was endemic in the past. No new rapid plasmin reagin (RPR) seroreactivity in young children is required for certification of elimination at a country level. We sought to evaluate whether antibody responses to specific treponemal antigens measured in a high-throughput multiplex bead array (MBA) assay differentiate past versus current infection and whether a nontreponemal lipoidal antigen test can be incorporated into the MBA. Serum and dried blood spot specimens collected for yaws surveillance projects in Ghana, Vanuatu, and Papua New Guinea (PNG) were run on MBA to measure antibodies against recombinant p17 (rp17) and treponemal membrane protein A (TmpA) treponemal antigens. Results were compared to standard treponemal laboratory (TPPA or TPHA [TPP(H)A]) and quantitative RPR test data. Of 589 specimens, 241 were TPP(H)A(+)/RPR(+), 88 were TPP(H)A(+)/RPR(-), 6 were TPP(H)A(-)/RPR(+), and 254 were negative for both tests. Compared to TPP(H)A, reactive concordance of rp17 was 93.7%, while reactive concordance of TmpA was only 81.9%. TmpA-specific reactivity showed good correlation with RPR titers (R(2) = 0.41; P < 0.0001). IgG responses to the lipoidal antigen used in RPR testing (cardiolipin) were not detected in the MBA. Our results suggest that TmpA can be used as a treponemal antigen marker for recent or active infection and potentially replace RPR in a high-throughput multiplex tool for large-scale yaws surveillance.

Indexed as

Epidemiological MonitoringAdolescentAntibodies, BacterialChildChild, PreschoolFemaleGhanaHigh-Throughput Screening AssaysHumansInfantMalePapua New GuineaSerologic TestsVanuatuYawsAntibodies, Bacterial

Identifiers

PMID26962086
PMCPMC4844712
OpenAlexW2293240724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.